Phase I study of duvelisib in patients with relapsed or refractory CLL
Listen now
Description
Dr O’Brien talks to ecancertv at the 2015 International Workshop on Chronic Lymphocytic Leukaemia (CLL) about the results of a new phase I study of duvelisib (IPI-145) in patients with relapsed or refractory CLL.
More Episodes
Published 08/11/17
Prof John Gribben (University London and Barts, London, UK) chairs a discussion for ecancertv at iwCLL 2015 with Prof Michael Hallek (University Clinic of Cologne, Cologne, Germany) Dr Michael Keating (University of Texas MD Anderson Cancer Center, Houston, USA) Prof Kanti Rai (Long Island Jewish...
Published 08/11/17
Professor Catovsky speaks to ecancertv at the 2015 International Workshop on Chronic Lymphocytic Leukaemia (CLL) about the long-term outcomes of the fludarabine plus cyclophosphamide in a randomised controlled trial for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial).
Published 08/11/17